InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
T+90 hit rate
25%
T+90 mean return
-8.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by DIEKMAN JOHN D, Director. Insider active across 1 company, notably Zai Lab Ltd. In total, 13 reports have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €627k. History available since 5 May 2021. The latest transaction was disclosed on 18 June 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
22,371 sharesAmerican Depositary SharesSEC:0000905148-26-003028:0
21,253 shares0American Depositary SharesSEC:0000905148-24-001747:0
18,903 shares@ US$26.4542.3% of flowAmerican Depositary SharesSEC:0000950170-23-031111:0
1,000 shares@ US$50.170.0019% mcap7.0% of flowOrdinary SharesSEC:0001567619-22-002713:0
1,000 shares@ US$50.174.0% of flowOrdinary SharesSEC:0001567619-22-002713
7,763 shares0Ordinary SharesSEC:0001567619-22-000393
7,763 shares0Ordinary SharesSEC:0001567619-22-000393:0
1,000 shares@ US$91.650.0034% mcap12.7% of flowOrdinary SharesSEC:0001567619-21-019472:0
1,000 shares@ US$91.657.3% of flowOrdinary SharesSEC:0001567619-21-019472
1,000 shares@ US$149.500.0055% mcap20.1% of flowOrdinary SharesSEC:0001567619-21-014550:0
1,000 shares@ US$149.5011.6% of flowOrdinary SharesSEC:0001567619-21-014550
1,000 sharesOrdinary SharesSEC:0001567619-21-009234
1,000 shares@ US$153.620.0055% mcap20.4% of flowOrdinary SharesSEC:0001567619-21-009234:0
13 of 13 declarations
About DIEKMAN JOHN D
John D. Diekman is a Board Member at Zai Lab Ltd, a biopharmaceutical company. As a board member, John contributes to the company's governance and the development of strategies aimed at enhancing its performance. His experience in the biopharmaceutical sector is an asset to the board.
